This inventor holds 2 USPTO granted patents. Top assignees: The University of Texas System, Sciclone Pharmaceuticals, Inc.. Active years: 2011-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2011-2012
Title: The Innovations of Clarence J Peters
Introduction
Clarence J Peters is a notable inventor based in Galveston, TX (US). He has made significant contributions to the field of immunology and virology, holding a total of 2 patents. His work focuses on the treatment and prevention of viral infections, showcasing his dedication to advancing medical science.
Latest Patents
Peters' latest patents include groundbreaking inventions. The first patent addresses the treatment or prevention of hemorrhagic viral infections with immunomodulator compounds. This invention involves administering an immunomodulatory compound to patients who are at risk of such infections. The second patent presents a reverse genetic system for the Rift Valley fever virus. This system comprises RNA expression plasmids and protein expression plasmids, which can be modified to generate a recombinant virus expressing a non-viral foreign gene. This innovative approach is aimed at developing anti-Rift Valley fever virus vaccines and screening antivirals.
Career Highlights
Throughout his career, Peters has worked with esteemed organizations such as the University of Texas System and Sciclone Pharmaceuticals, Inc. His experience in these institutions has allowed him to collaborate with other experts in the field and contribute to significant advancements in medical research.
Collaborations
Peters has collaborated with notable individuals such as Shinji Makino and Tetsuro Ikegami. These partnerships have further enriched his research and innovation efforts.
Conclusion
Clarence J Peters is a distinguished inventor whose work in immunology and virology has led to important advancements in the treatment of viral infections. His patents reflect a commitment to improving public health through innovative solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile